Elicio Therapeutics, Inc. Finance Lease, Liability, Noncurrent
Elicio Therapeutics, Inc. (ELTX) had Finance Lease, Liability, Noncurrent of $0 as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2023-05-10
- 2023-03-31: Finance Lease, Liability, Noncurrent $0.00.
- 2022-12-31: Finance Lease, Liability, Noncurrent $168.00K.
- 2022-09-30: Finance Lease, Liability, Noncurrent $186.00K.
- 2022-06-30: Finance Lease, Liability, Noncurrent $202.00K.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-12-31 | $168.00K 10-Q · filed 2023-05-10 |
| 2022-09-30 | $186.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $202.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $219.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $235.00K 10-K · filed 2023-03-17 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |